Showing results (91-100 of 236) with videos related to

Sort By:
Pageof 24
Rheumatology (Oxford, England)|January 9, 2025
Differences in phenotypes, treatments, and outcomes of ANCA-associated vasculitis across Europe, Japan and the USA in 2020Satoshi Omura, Takashi Kida, Andreas Kronbichler, et al.
American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remissionGabriele Gamerith, Finn Mildner, Peter A Merkel, et al.
The Journal of Rheumatology|August 9, 2008
Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestationsPhilip Seo, Ulrich Specks, Karina A Keogh
Current Rheumatology Reports|April 1, 2017
ANCA-Associated Vasculitis Pathogenesis: A CommentaryEric J Gapud, Philip Seo, Brendan Antiochos
Kidney International Reports|June 2, 2018
Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive HistologyTessa K Novick, Min Chen, Jennifer Scott, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 21, 2023
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular DiseasesLaurence H Beck, Isabelle Ayoub, Dawn Caster, et al.
American Journal of Nephrology|November 26, 2018
Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody GlomerulonephritisSteven Menez, Zdenka Hruskova, Jennifer Scott, et al.
American Journal of Nephrology|June 6, 2015
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximabShivani Shah, Zdenka Hruskova, Marten Segelmark, et al.
Pageof 24